Bristol Myers Squibb Co. (BMY)
66.81
+0.23
(+0.35%)
USD |
NYSE |
Aug 31, 16:00
66.99
+0.18
(+0.27%)
Pre-Market: 07:22
Bristol Myers Squibb Net Income (TTM) : 9.275B for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.275B |
| March 31, 2026 | 7.272B |
| December 31, 2025 | 7.056B |
| September 30, 2025 | 6.046B |
| June 30, 2025 | 5.066B |
| March 31, 2025 | 5.437B |
| December 31, 2024 | -8.933B |
| September 30, 2024 | -7.247B |
| June 30, 2024 | -6.528B |
| March 31, 2024 | -6.135B |
| December 31, 2023 | 8.04B |
| September 30, 2023 | 8.303B |
| June 30, 2023 | 7.977B |
| March 31, 2023 | 7.329B |
| December 31, 2022 | 6.345B |
| September 30, 2022 | 6.692B |
| June 30, 2022 | 6.636B |
| March 31, 2022 | 6.268B |
| December 31, 2021 | 7.014B |
| September 30, 2021 | -5.385B |
| June 30, 2021 | -5.059B |
| March 31, 2021 | -6.20B |
| December 31, 2020 | -8.995B |
| September 30, 2020 | -28.00M |
| June 30, 2020 | -540.00M |
| Date | Value |
|---|---|
| March 31, 2020 | 979.00M |
| December 31, 2019 | 3.46B |
| September 30, 2019 | 5.71B |
| June 30, 2019 | 6.256B |
| March 31, 2019 | 5.199B |
| December 31, 2018 | 4.979B |
| September 30, 2018 | 1.46B |
| June 30, 2018 | 404.00M |
| March 31, 2018 | 944.00M |
| December 31, 2017 | 975.00M |
| September 30, 2017 | 4.202B |
| June 30, 2017 | 4.561B |
| March 31, 2017 | 4.827B |
| December 31, 2016 | 4.507B |
| September 30, 2016 | 3.48B |
| June 30, 2016 | 2.995B |
| March 31, 2016 | 1.697B |
| December 31, 2015 | 1.69B |
| September 30, 2015 | 1.846B |
| June 30, 2015 | 1.848B |
| March 31, 2015 | 2.292B |
| December 31, 2014 | 2.029B |
| September 30, 2014 | 2.737B |
| June 30, 2014 | 2.697B |
| March 31, 2014 | 2.893B |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Johnson & Johnson | 21.04B |
| Eli Lilly & Co. | 26.71B |
| Merck & Co., Inc. | 3.169B |
| Pfizer Inc. | 4.373B |
| AstraZeneca PLC | 10.40B |